0000950170-24-029647.txt : 20240312 0000950170-24-029647.hdr.sgml : 20240312 20240312070549 ACCESSION NUMBER: 0000950170-24-029647 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240310 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240312 DATE AS OF CHANGE: 20240312 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STAAR SURGICAL CO CENTRAL INDEX KEY: 0000718937 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 953797439 STATE OF INCORPORATION: DE FISCAL YEAR END: 1230 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-11634 FILM NUMBER: 24740168 BUSINESS ADDRESS: STREET 1: 1911 WALKER AVE CITY: MONROVIA STATE: CA ZIP: 91016 BUSINESS PHONE: 6263037902 MAIL ADDRESS: STREET 1: 1911 WALKER AVE CITY: MONROVIA STATE: CA ZIP: 91016 FORMER COMPANY: FORMER CONFORMED NAME: STAAR SURGICAL COMPANY DATE OF NAME CHANGE: 19920703 8-K 1 staa-20240310.htm 8-K 8-K
false000071893700007189372024-03-102024-03-10

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): March 10, 2024

 

 

STAAR Surgical Company

(Exact Name of Registrant as Specified in Charter)

 

 

Delaware

0-11634

95-3797439

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

 

 

25651 Atlantic Ocean Drive

Lake Forest, California

92630

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s Telephone Number, Including Area Code: 626-303-7902

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common

STAA

NASDAQ

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1 933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 10, 2024, the Board of Directors (the “Board”) of STAAR Surgical Company (the “Company”) voted to increase the size of the Board from six (6) directors to eight (8) directors and appointed to the Board two new directors, Arthur Butcher and Wei Jiang, effective March 12, 2024.

Arthur Butcher, age 53, brings to the Company extensive medical device marketing, strategy and product development experience, including significant business experience in Asia. Mr. Butcher currently serves as Executive Vice President and Group President, MedSurg and Asia Pacific for Boston Scientific, a position he has held since May 2022. Prior to his current role, Mr. Butcher served as Boston Scientific’s Executive Vice President and President, Asia Pacific, from February 2020 to May 2022, and was responsible for commercialization of the company’s full portfolio of products across all divisions in the Asia Pacific region. Mr. Butcher joined Boston Scientific in 1997, and he has held management roles with increasing responsibility and has deep experience across the company’s divisions. He currently serves as a member of the Board of Directors of Acotec Scientific Holdings Limited, listed publicly on the Hong Kong Stock Exchange. Mr. Butcher received a B.A. in International Relations from the University of Pennsylvania and an M.B.A. from Columbia University.

Wei Jiang, age 60, brings to the Company more than 25 years’ experience in the pharmaceutical and medical device industries, with particular focus in China and the Asia/Pacific region. Mr. Jiang most recently served as Executive Vice President and President, Bayer Pharmaceuticals Region China & APAC, and President, Bayer Group Greater China Region, until his retirement in 2021. Prior to joining Bayer in 2012, he held various senior positions at AstraZeneca, culminating in his role as Senior Vice President, China operations. Prior to that, Mr. Jiang served as Managing Director, China operations at Guidant Corporation and in various roles at Eli Lilly & Company including Marketing Director, China Operations. He currently serves as a member of the Board of Directors of Waters Corporation, listed publicly on the New York Stock Exchange. Mr. Jiang received a B.BA. in business administration from Campbell University in North Carolina and an M.A. in economics from Indiana State University.

The appointment of each of Messrs. Butcher and Jiang to the Board was not the result of any arrangement or understanding with any other person or entity. There are no transactions between Mr. Butcher or Mr. Jiang, nor any member of their immediate families, and the Company or any of its subsidiaries.

The Board also voted to provide each of Messrs. Butcher and Jiang with the standard director compensation for a non-employee director, pro-rated for the remaining portion of the 2023-2024 term.

In addition, director K. Peony Yu has indicated that she does not intend to stand for re-election to the Board upon the expiration of her term as a director at the Corporation’s 2024 Annual Meeting of Shareholders (the “Annual Meeting”). The Board voted to nominate for re-election to the Board at the Annual Meeting directors Arthur Butcher, Stephen Farrell, Thomas Frinzi, Wei Jiang, Aimee Weisner, Elizabeth Yeu, and Lilian Zhou. In addition, the Board voted to reduce the size of the Board from eight (8) directors to seven (7) directors upon the expiration of Dr. Yu’s term as a director.

 

Item 7.01 Regulation FD Disclosure.

On March 12, 2024, the Company issued a press release regarding the appointment of Messrs. Butcher and Jiang to the Board. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.

The information furnished herewith pursuant to Item 7.01 of this Current Report, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in Item 7.01 of this Current Report and Exhibit 99.1 shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing.

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.

Description

 

 

 

99.1

Press release of the Company dated March 12, 2024.

 

 

 

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

STAAR Surgical Company

March 12, 2024

By:

/s/ Tom Frinzi

Thomas G. Frinzi

President and Chief Executive Officer

 

 EX-99.1 2 staa-ex99_1.htm EX-99.1 EX-99.1

Exhibit 99.1

img177331332_0.jpg 

STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors

 

LAKE FOREST, CA, March 12, 2024 --- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced the appointment of Arthur Butcher, Executive Vice President and Group President, MedSurg and Asia Pacific for Boston Scientific, and Wei Jiang, retired Executive Vice President and President of Bayer Pharmaceuticals Region China & APAC, to its Board of Directors, effective March 12, 2024.

 

“Art Butcher and Wei Jiang are seasoned executives with broad leadership experience built over decades at two of the most highly regarded global companies in the healthcare industry,” said Aimee Weisner, Chair of the Nominating and Governance Committee of STAAR Surgical’s Board of Directors. "Art and Wei also have particular expertise in APAC, the largest market in the world for refractive vision correction. We welcome them to the Board and look forward to leveraging their insights during this period of accelerating growth and innovation at STAAR.”

 

Arthur Butcher brings extensive medical device marketing, strategy and product development experience, including significant business experience in Asia. Mr. Butcher currently serves as Executive Vice President and Group President, MedSurg and Asia Pacific for Boston Scientific, a position he has held since May 2022. Prior to his current role, Mr. Butcher was responsible for commercialization of the company’s full portfolio of products across all divisions in the Asia Pacific region. Mr. Butcher joined Boston Scientific in 1997. He currently serves as a member of the Board of Directors of Acotec Scientific Holdings Limited, listed publicly on the Hong Kong Stock Exchange. Mr. Butcher received a B.A. in International Relations from the University of Pennsylvania and an MBA from Columbia University.

 

Wei Jiang brings more than 25 years’ experience in the pharmaceutical and medical device industries, with particular focus in China and the Asia/Pacific region. Mr. Jiang most recently served as Executive Vice President, Bayer Pharmaceuticals Region China & APAC, and President, Bayer Group Greater China Region, until his retirement in 2021. Prior to joining Bayer in 2012, he held various senior positions at AstraZeneca, culminating in his role as Senior Vice President, China operations. Prior to that, Mr. Jiang served as Managing Director, China operations at Guidant Corporation and in various roles at Eli Lilly & Company including Marketing Director, China Operations. He currently serves as a member of the Board of Directors of Waters Corporation, listed publicly on the New York Stock Exchange. Mr. Jiang received a B.BA. in business administration from Campbell University in North Carolina and an M.A. in economics from Indiana State University.

 

STAAR also announced today that director K. Peony Yu., M.D., has indicated that she does not intend to stand for re-election to the Board upon the expiration of her current term in June 2024. Tom Frinzi, STAAR’s Chair of the Board, stated, “Peony leveraged her vast clinical and patient knowledge as a Board member, and STAAR appreciates her many contributions to our Board during her tenure. Peony has been an important part of governance and decision-making during her more than three years on the Board, and she helped us build a strong foundation for future growth. We wish her the best in her future endeavors.”

 

With the appointment of Messrs. Butcher and Jiang to the Board, the STAAR Surgical Board is now comprised of eight directors, seven of whom are independent non-employee directors. Other current members of the Board include Stephen Farrell, Tom Frinzi, Aimee Weisner, Elizabeth Yeu, M.D., K. Peony Yu, M.D., and Lilian Zhou, CFA.

 

 

 

 

About STAAR Surgical

 

STAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL,” which includes the EVO ICL™ product line. More than 2,500,000 ICLs have been sold to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: EVOICL.com. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more information, please visit the Company’s website at www.staar.com.

 

CONTACT:

Investors & Media

Brian Moore

Vice President, Investor Relations and Corporate Development

(626) 303-7902, Ext. 3023

bmoore@staar.com

 

2

 

 GRAPHIC 3 img177331332_0.jpg GRAPHIC begin 644 img177331332_0.jpg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staa-20240310.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, State or Province Entity Address, State or Province Trading Symbol(s) Trading Symbol Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Written Communications Written Communications Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity Registrant Name Entity Registrant Name Document Period End Date Document Period End Date Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Local Phone Number Local Phone Number City Area Code City Area Code Pre-commencement Tender Offer Pre-commencement Tender Offer Cover [Abstract] Name of each exchange on which registered Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Amendment Flag Amendment Flag Entity File Number Securities Act File Number Entity Address, Address Line One Entity Address, Address Line One Title of each class Title of 12(b) Security Document Type Document Type XML 5 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document And Entity Information
Mar. 10, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 10, 2024
Entity Registrant Name STAAR Surgical Co
Entity Central Index Key 0000718937
Entity Emerging Growth Company false
Entity File Number 0-11634
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 95-3797439
Entity Address, Address Line One 25651 Atlantic Ocean Drive
Entity Address, City or Town Lake Forest
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92630
City Area Code 626
Local Phone Number 303-7902
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of each class Common
Trading Symbol(s) STAA
Name of each exchange on which registered NASDAQ
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports staa-20240310.htm staa-20240310.xsd http://xbrl.sec.gov/dei/2023 false false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "staa-20240310.htm": { "nsprefix": "staa", "nsuri": "http://www.staar.com/20240310", "dts": { "inline": { "local": [ "staa-20240310.htm" ] }, "schema": { "local": [ "staa-20240310.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_f2dcc0e2-8fb5-4410-9fd5-0d18e1a72033", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "staa-20240310.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_f2dcc0e2-8fb5-4410-9fd5-0d18e1a72033", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "staa-20240310.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Securities Act File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Title of each class", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Name of each exchange on which registered", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol(s)", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.staar.com/20240310/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 14 0000950170-24-029647-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-029647-xbrl.zip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

'-D[5UM;]LX$OZ^OX+K_=)B5Y;M--V-T63A3=J# ML6D3)"EN<8=#(4NT+2PM^B@IL?_]#271$252=FJ'DJ'KAT:11@^?&;X-AQKF MP^^K!4&/F(4^#=K_?6Z/YR/.[\?O'#AQ\M"UU]&G]! M7_ 3&KF1_XBO_- E-(P91F_N/[]%?_UQ=XWNW3E>..B*NO$"!Q&RT#R*ED/; M?GIZZGI3/P@IB2,H+NRZ=&$CR\K +QEV^'UTY408#0>]P3NK=V+U^P_]L^&[ ML^'):?>W]X/>S[W>L-?+O4:7:^;/YA%ZX[Y%_"TH.P@P(6OTR0^

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end XML 15 staa-20240310_htm.xml IDEA: XBRL DOCUMENT 0000718937 2024-03-10 2024-03-10 false 0000718937 8-K 2024-03-10 STAAR Surgical Co DE 0-11634 95-3797439 25651 Atlantic Ocean Drive Lake Forest CA 92630 626 303-7902 false false false false Common STAA NASDAQ false